Western Asset Investment Grade Defined Opportunity Trust Inc. (IGI)
Price:
16.65 USD
( - -0.08 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
State Street Corporation
VALUE SCORE:
10
2nd position
FS Credit Opportunities Corp.
VALUE SCORE:
13
The best
ClearBridge Energy Midstream Opportunity Fund Inc
VALUE SCORE:
15
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
DESCRIPTION
Western Asset Investment Grade Defined Opportunity Trust Inc. is a close-ended fixed income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. It is co-managed by Western Asset Management Company, Western Asset Management Company Pte. Ltd, Western Asset Management Company Ltd., and Western Asset Management Company Limited. The fund invests in fixed income markets of the United States. It seeks to invest in securities of companies operating across diversified sectors. The fund primarily invests in investment-grade corporate debt securities with varied maturities. It will liquidate on or about December 2, 2024. The fund conducts in-house research to make its investments. Western Asset Investment Grade Defined Opportunity Trust Inc. was formed on June 26, 2009 and is domiciled in the United States.
NEWS
IGI to Release Third Quarter and Nine Month 2025 Financial Results on November 4, 2025
businesswire.com
2025-10-08 09:00:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it expects to release financial results for the third quarter and first nine months of 2025, on Tuesday, November 4, 2025, after the close of the U.S. financial markets. The results, along with an accompanying slide presentation, will be posted in the Investors section of the Company website at www.iginsure.com. The Company will host an investor teleconf.
Western Asset Investment Grade Opportunity Trust Inc. (NYSE: IGI) Announces Portfolio Management Team Update
businesswire.com
2025-08-19 08:00:00NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.
IGI Announces Quarterly Ordinary Common Share Dividend
businesswire.com
2025-08-14 16:05:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that its Board of Directors has declared an ordinary common share dividend of $0.05 per share for the period April 1, 2025 – June 30, 2025. The dividend is payable on September 16, 2025 to shareholders of record at the close of business on September 1, 2025. About IGI: IGI is an international specialty risks commercial insurer and reinsurer underwriting a div.
IGI Reports Second Quarter and Half Year 2025 Unaudited Financial Results
businesswire.com
2025-08-05 16:10:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today reported financial results for the second quarter and first six months of 2025. Highlights for the second quarter and first six months of 2025 include: (in millions of U.S. Dollars, except percentages and per share information) Quarter Ended June 30, Six Months Ended June 30, 2025 2024 2025 2024 Gross written premiums $187.8 $205.6 $394.3 $387.2 Net premiums earned.
India's Glenmark Pharma unit, Abbvie sign exclusive licensing pact
reuters.com
2025-07-10 07:44:30India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have signed an exclusive global licensing agreement for IGI's cancer treatment, ISB 2001.
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
globenewswire.com
2025-07-10 07:35:00Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
prnewswire.com
2025-07-10 07:30:00ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) NORTH CHICAGO, Ill. and NEW YORK , July 10, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive licensing agreement for IGI's lead investigational asset, ISB 2001, developed using IGI's proprietary BEAT® protein platform, for oncology and autoimmune diseases.
IGI to Release Second Quarter and Half Year 2025 Financial Results on August 5, 2025
businesswire.com
2025-07-09 09:00:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it expects to release financial results for the second quarter and half year 2025, on Tuesday, August 5, 2025, after the close of the U.S. financial markets. The results, along with an accompanying slide presentation, will be posted in the Investors section of the Company website at www.iginsure.com. The Company will host an investor teleconference, incl.
IGI Announces Increase in Quarterly Ordinary Common Share Dividend
businesswire.com
2025-05-15 16:05:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that its Board of Directors has voted to increase the Company's quarterly ordinary common share dividend to $0.05 per share, representing a 100% increase from the present rate of $0.025 per share per quarter. The first regular quarterly ordinary common share dividend at the new rate of $0.05 will be paid on June 18, 2025, to shareholders of record at the clos.
IGI Reports First Quarter of 2025 Unaudited Financial Results
businesswire.com
2025-05-06 16:05:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today reported financial results for the first quarter of 2025. Highlights for the first quarter of 2025 include: (in millions of U.S. Dollars, except percentages and per share information) Quarter Ended March 31, 2025 2024 Gross written premiums $206.5 $181.6 Net premiums earned $112.8 $114.5 Underwriting income (1) $27.9 $52.0 Net investment income $15.5 $15.4 Net inco.
Western Asset Investment Grade Opportunity Trust Inc. Announces Results of Annual Meeting of Stockholders
businesswire.com
2025-04-17 08:00:00NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.
Western Asset Investment Grade Opportunity Trust Inc. Announces Financial Position as of February 28, 2025
businesswire.com
2025-04-16 08:00:00NEW YORK--(BUSINESS WIRE)--Category: Financials.
IGI Announces That It Has Filed Its Full Year 2024 Annual Report on Form 20-F, Including Audited Financial Statements, with the SEC
businesswire.com
2025-04-02 09:00:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it has filed its Annual Report on Form 20-F, which includes the Company's audited financial statements for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission (“SEC”). The report was filed on April 1, 2025 and can be found on IGI's website at www.iginsure.com in the Investors section under SEC Filings or on the SEC's websit.
IGI Declares Extraordinary Cash Dividend and Regular Ordinary Common Share Dividend
businesswire.com
2025-03-19 16:05:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that its Board of Directors has declared an extraordinary cash dividend of $0.85 per common share for the period October 1, 2024 – December 31, 2024, in addition to the Company's regular quarterly common share dividend of $0.025 per share. The extraordinary dividend plus the regular quarterly dividend, totaling $0.875, is payable on April 22, 2025 to sharehol.
IGI to Release Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
businesswire.com
2025-01-21 09:00:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it expects to release financial results for the fourth quarter and full year 2024, on Tuesday, February 25, 2025, after the close of the U.S. financial markets. The results, along with an accompanying slide presentation, will be posted in the Investors section of the Company website at www.iginsure.com. The Company will host an investor teleconference, i.
Closed-End Funds: Screening For Potential Opportunites To Kick Off Q1 2025
seekingalpha.com
2025-01-13 15:59:32The closed-end fund space saw a significant narrowing of discounts throughout 2024 as equity markets charged higher and now discounts remain tight heading into 2025. In particular, equity CEFs have seen significantly narrowed discounts along with taxable fixed-income, though municipal bond funds look relatively attractive after widening discounts in December. We are screening for funds with the deepest discounts and widest z-scores to find potential buys and funds that may be getting a bit pricey as sell candidates.
IGI to Release Third Quarter and Nine Month 2025 Financial Results on November 4, 2025
businesswire.com
2025-10-08 09:00:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it expects to release financial results for the third quarter and first nine months of 2025, on Tuesday, November 4, 2025, after the close of the U.S. financial markets. The results, along with an accompanying slide presentation, will be posted in the Investors section of the Company website at www.iginsure.com. The Company will host an investor teleconf.
Western Asset Investment Grade Opportunity Trust Inc. (NYSE: IGI) Announces Portfolio Management Team Update
businesswire.com
2025-08-19 08:00:00NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.
IGI Announces Quarterly Ordinary Common Share Dividend
businesswire.com
2025-08-14 16:05:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that its Board of Directors has declared an ordinary common share dividend of $0.05 per share for the period April 1, 2025 – June 30, 2025. The dividend is payable on September 16, 2025 to shareholders of record at the close of business on September 1, 2025. About IGI: IGI is an international specialty risks commercial insurer and reinsurer underwriting a div.
IGI Reports Second Quarter and Half Year 2025 Unaudited Financial Results
businesswire.com
2025-08-05 16:10:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today reported financial results for the second quarter and first six months of 2025. Highlights for the second quarter and first six months of 2025 include: (in millions of U.S. Dollars, except percentages and per share information) Quarter Ended June 30, Six Months Ended June 30, 2025 2024 2025 2024 Gross written premiums $187.8 $205.6 $394.3 $387.2 Net premiums earned.
India's Glenmark Pharma unit, Abbvie sign exclusive licensing pact
reuters.com
2025-07-10 07:44:30India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have signed an exclusive global licensing agreement for IGI's cancer treatment, ISB 2001.
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
globenewswire.com
2025-07-10 07:35:00Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
prnewswire.com
2025-07-10 07:30:00ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) NORTH CHICAGO, Ill. and NEW YORK , July 10, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive licensing agreement for IGI's lead investigational asset, ISB 2001, developed using IGI's proprietary BEAT® protein platform, for oncology and autoimmune diseases.
IGI to Release Second Quarter and Half Year 2025 Financial Results on August 5, 2025
businesswire.com
2025-07-09 09:00:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it expects to release financial results for the second quarter and half year 2025, on Tuesday, August 5, 2025, after the close of the U.S. financial markets. The results, along with an accompanying slide presentation, will be posted in the Investors section of the Company website at www.iginsure.com. The Company will host an investor teleconference, incl.
IGI Announces Increase in Quarterly Ordinary Common Share Dividend
businesswire.com
2025-05-15 16:05:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that its Board of Directors has voted to increase the Company's quarterly ordinary common share dividend to $0.05 per share, representing a 100% increase from the present rate of $0.025 per share per quarter. The first regular quarterly ordinary common share dividend at the new rate of $0.05 will be paid on June 18, 2025, to shareholders of record at the clos.
IGI Reports First Quarter of 2025 Unaudited Financial Results
businesswire.com
2025-05-06 16:05:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today reported financial results for the first quarter of 2025. Highlights for the first quarter of 2025 include: (in millions of U.S. Dollars, except percentages and per share information) Quarter Ended March 31, 2025 2024 Gross written premiums $206.5 $181.6 Net premiums earned $112.8 $114.5 Underwriting income (1) $27.9 $52.0 Net investment income $15.5 $15.4 Net inco.
Western Asset Investment Grade Opportunity Trust Inc. Announces Results of Annual Meeting of Stockholders
businesswire.com
2025-04-17 08:00:00NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.
Western Asset Investment Grade Opportunity Trust Inc. Announces Financial Position as of February 28, 2025
businesswire.com
2025-04-16 08:00:00NEW YORK--(BUSINESS WIRE)--Category: Financials.
IGI Announces That It Has Filed Its Full Year 2024 Annual Report on Form 20-F, Including Audited Financial Statements, with the SEC
businesswire.com
2025-04-02 09:00:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it has filed its Annual Report on Form 20-F, which includes the Company's audited financial statements for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission (“SEC”). The report was filed on April 1, 2025 and can be found on IGI's website at www.iginsure.com in the Investors section under SEC Filings or on the SEC's websit.
IGI Declares Extraordinary Cash Dividend and Regular Ordinary Common Share Dividend
businesswire.com
2025-03-19 16:05:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that its Board of Directors has declared an extraordinary cash dividend of $0.85 per common share for the period October 1, 2024 – December 31, 2024, in addition to the Company's regular quarterly common share dividend of $0.025 per share. The extraordinary dividend plus the regular quarterly dividend, totaling $0.875, is payable on April 22, 2025 to sharehol.
IGI to Release Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
businesswire.com
2025-01-21 09:00:00HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it expects to release financial results for the fourth quarter and full year 2024, on Tuesday, February 25, 2025, after the close of the U.S. financial markets. The results, along with an accompanying slide presentation, will be posted in the Investors section of the Company website at www.iginsure.com. The Company will host an investor teleconference, i.
Closed-End Funds: Screening For Potential Opportunites To Kick Off Q1 2025
seekingalpha.com
2025-01-13 15:59:32The closed-end fund space saw a significant narrowing of discounts throughout 2024 as equity markets charged higher and now discounts remain tight heading into 2025. In particular, equity CEFs have seen significantly narrowed discounts along with taxable fixed-income, though municipal bond funds look relatively attractive after widening discounts in December. We are screening for funds with the deepest discounts and widest z-scores to find potential buys and funds that may be getting a bit pricey as sell candidates.